![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 11, 8949-8954, March 15, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
¶
From the Escherichia coli DNA gyrase is
comprised of two subunits, GyrA and GyrB. Previous studies have shown
that GyrI, a regulatory factor of DNA gyrase activity, inhibits the
supercoiling activity of DNA gyrase and that both overexpression and
antisense expression of the gyrI gene suppress cell
proliferation. Here we have analyzed the interaction of GyrI with DNA
gyrase using two approaches. First, immunoprecipitation experiments
revealed that GyrI interacts preferentially with the holoenzyme in an
ATP-independent manner, although a weak interaction was also detected
between GyrI and the individual GyrA and GyrB subunits. Second, surface
plasmon resonance experiments indicated that GyrI binds to the gyrase holoenzyme with higher affinity than to either the GyrA or GyrB subunit
alone. Unlike quinolone antibiotics, GyrI was not effective in
stabilizing the cleavable complex consisting of gyrase and DNA.
Further, we identified an 8-residue synthetic peptide, corresponding to
amino acids 89ITGGQYAV96 of GyrI, which
inhibits gyrase activity in an in vitro supercoiling assay.
Surface plasmon resonance analysis of the ITGGQYAV-containing peptide-gyrase interaction indicated a high association constant for
this interaction. These results suggest that amino acids 89-96 of GyrI
are essential for its interaction with, and inhibition of, DNA gyrase.
Cellular Physiology Laboratory, the
Institute of Physical and Chemical Research (RIKEN), 2-1 Hirosawa,
Wako, Saitama 351-0198, the § Institute of Medical Science,
Tokyo University, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108, and the
¶ Institute for Molecular and Cellular Biology, Osaka University
and CREST, Japan Science and Technology Corporation,
Suita, Osaka 565-0871, Japan
To whom correspondence should be addressed: Institute for
Molecular and Cellular Biology, Osaka University, 1-3 Yamada-oka, Suita, Osaka 565-0871, Japan. Tel.: 81-6-6879-7975; Fax:
81-6-6877-9382; E-mail: fhanaoka@imcb.osaka-u.ac.jp.
This article has been cited by other articles:
![]() |
K. Champion and N. P. Higgins Growth Rate Toxicity Phenotypes and Homeostatic Supercoil Control Differentiate Escherichia coli from Salmonella enterica Serovar Typhimurium J. Bacteriol., August 15, 2007; 189(16): 5839 - 5849. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Hegde, M. W. Vetting, S. L. Roderick, L. A. Mitchenall, A. Maxwell, H. E. Takiff, and J. S. Blanchard A Fluoroquinolone Resistance Protein from Mycobacterium tuberculosis That Mimics DNA Science, June 3, 2005; 308(5727): 1480 - 1483. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Tran, G. A. Jacoby, and D. C. Hooper Interaction of the Plasmid-Encoded Quinolone Resistance Protein Qnr with Escherichia coli DNA Gyrase Antimicrob. Agents Chemother., January 1, 2005; 49(1): 118 - 125. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |